BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25329075)

  • 1. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.
    Rangasamy S; McGuire PG; Franco Nitta C; Monickaraj F; Oruganti SR; Das A
    PLoS One; 2014; 9(10):e108508. PubMed ID: 25329075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic Profiling Reveals Chemokine CXCL1 as a Mediator for Neutrophil Recruitment Associated With Blood-Retinal Barrier Alteration in Diabetic Retinopathy.
    Monickaraj F; Acosta G; Cabrera AP; Das A
    Diabetes; 2023 Jun; 72(6):781-794. PubMed ID: 36930735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation.
    Kokona D; Ebneter A; Escher P; Zinkernagel MS
    J Neuroinflammation; 2018 Dec; 15(1):340. PubMed ID: 30541565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy.
    Monickaraj F; McGuire PG; Nitta CF; Ghosh K; Das A
    FASEB J; 2016 Apr; 30(4):1670-82. PubMed ID: 26718887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
    Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
    J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
    Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
    Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
    Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
    Kim SR; Suh W
    Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.
    Al-Shabrawey M; Bartoli M; El-Remessy AB; Ma G; Matragoon S; Lemtalsi T; Caldwell RW; Caldwell RB
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3231-8. PubMed ID: 18378570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies.
    Lupo G; Motta C; Giurdanella G; Anfuso CD; Alberghina M; Drago F; Salomone S; Bucolo C
    Biochem Pharmacol; 2013 Dec; 86(11):1603-13. PubMed ID: 24076420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10-induced modulation of macrophage polarization suppresses outer-blood-retinal barrier disruption in the streptozotocin-induced early diabetic retinopathy mouse model.
    Lee SJ; Noh SE; Jo DH; Cho CS; Park KS; Kim JH
    FASEB J; 2024 May; 38(9):e23638. PubMed ID: 38713098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.
    Rangasamy S; Srinivasan R; Maestas J; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3784-91. PubMed ID: 21310918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature.
    Zhang C; Lai MB; Pedler MG; Johnson V; Adams RH; Petrash JM; Chen Z; Junge HJ
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2691-2705. PubMed ID: 30354230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
    Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
    Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.